Company profile
Arcus Biosciences, Inc. Insider Trading
RCUSEvery SEC Form 4 insider trading filing for Arcus Biosciences, Inc. (RCUS) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- NYSE
- Sector
- Pharmaceutical Preparations
- CIK
- 0001724521
- Filings
- 131
- Insiders
- 16
- Last filing
- 2026-08-21
Activity summary
No insider transactions in the last 30 days. The most recent was on August 21, 2026, when Alexander Azoy bought 2,827 shares. 131 filings from 16 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Arcus Biosciences, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $320.0M.
90 day insight
Over the last 90 days, Arcus Biosciences, Inc. insiders filed 6 Form 4 transactions, none of which were open-market purchases or sales.
- Most active insider: Juan C. Jaen with 3 transactions totaling $2.0M.
- Largest single sale: $1.5M by Juan C. Jaen on Jul 9, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | Alexander Azoy | RCUS | Option Exercise10b5 | 2,827 | $15.44 | $44K |
| Aug 21, 2026 | Alexander Azoy | RCUS | Sale10b5 | 2,827 | $30.00 | $85K |
| Aug 21, 2026 | Alexander Azoy | RCUS | Option Exercise10b5 | 2,827 | — | — |
| Jul 10, 2026 | Juan C. Jaen | RCUS | Sale10b5 | 19,799 | $28.61 | $566K |
| Jul 10, 2026 | Juan C. Jaen | RCUS | Sale10b5 | 268 | $29.40 | $8K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=RCUS" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Arcus Biosciences, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →